Sonodynamic Therapy Based on Combined Use of Low Dose Administration of Epirubicin-Incorporating Drug Delivery System and Focused Ultrasound

Masanori Maeda, Yoshihiro Muragaki, Jun Okamoto, Shin Yoshizawa, Nobutaka Abe, Hidekazu Nakamoto, Hiroshi Ishii, Kenichi Kawabata, Shinichiro Umemura, Nobuhiro Nishiyama, Kazunori Kataoka, Hiroshi Iseki

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    Sonodynamic therapy (SDT) is currently considered as one of the promising minimally invasive treatment options for solid cancers. SDT is based on the combined use of a sonosensitizer drug and high-intensity focused ultrasound (HIFU) to produce cytotoxic reactive oxygen species (ROS) in and around neoplastic cells. Anthracycline drugs, including epirubicin (EPI), have been well known as effective sonosensitizers after interaction with focused ultrasound. Recently a new anticancer drug delivery system (DDS), NC-6300, has been developed that comprises EPI through an acid–labile hydrazone bond. In previous in vivo studies, NC-6300 showed basic drug safety and an excellent concentration property of EPI, and recently has been tested in clinical trials. For realizing minimally invasive cancer treatment, the present study demonstrated the effectiveness and feasibility of DDS-based SDT, which combined a small dose of NC-6300 and low energy of HIFU in mouse models of colon cancer and pancreatic cancer.

    Original languageEnglish
    Pages (from-to)2295-2301
    Number of pages7
    JournalUltrasound in Medicine and Biology
    Volume43
    Issue number10
    DOIs
    Publication statusPublished - 2017 Oct

    Keywords

    • Colon cancer
    • Drug delivery system (DDS)
    • Epirubicin
    • High intensity focused ultrasound (HIFU)
    • In vivo
    • Micellar
    • Pancreatic cancer
    • Sonodynamic therapy (SDT)

    ASJC Scopus subject areas

    • Biophysics
    • Radiological and Ultrasound Technology
    • Acoustics and Ultrasonics

    Fingerprint Dive into the research topics of 'Sonodynamic Therapy Based on Combined Use of Low Dose Administration of Epirubicin-Incorporating Drug Delivery System and Focused Ultrasound'. Together they form a unique fingerprint.

  • Cite this

    Maeda, M., Muragaki, Y., Okamoto, J., Yoshizawa, S., Abe, N., Nakamoto, H., Ishii, H., Kawabata, K., Umemura, S., Nishiyama, N., Kataoka, K., & Iseki, H. (2017). Sonodynamic Therapy Based on Combined Use of Low Dose Administration of Epirubicin-Incorporating Drug Delivery System and Focused Ultrasound. Ultrasound in Medicine and Biology, 43(10), 2295-2301. https://doi.org/10.1016/j.ultrasmedbio.2017.06.003